Eliem Therapeutics Price on July 8, 2024
ELYMDelisted Stock | USD 3.09 0.06 1.90% |
If you're considering investing in Eliem Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eliem Therapeutics stands at 3.09, as last reported on the 17th of December 2024, with the highest price reaching 3.19 and the lowest price hitting 3.07 during the day. Eliem Therapeutics secures Sharpe Ratio (or Efficiency) of -0.32, which denotes the company had a -0.32% return per unit of risk over the last 3 months. Eliem Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eliem Therapeutics' Mean Deviation of 3.62, variance of 23.13, and Standard Deviation of 4.81 to check the risk estimate we provide.
Eliem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Eliem |
Sharpe Ratio = -0.3219
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ELYM |
Estimated Market Risk
4.85 actual daily | 43 57% of assets are more volatile |
Expected Return
-1.56 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.32 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eliem Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eliem Therapeutics by adding Eliem Therapeutics to a well-diversified portfolio.
Related Headline
MediciNova Headline on 8th of July 2024
Acquisition by Beaver Carolyn of 20000 shares of MediciNova ... by Beaver Carolyn
Filed transaction by MediciNova Director. Grant, award or other acquisition pursuant to Rule 16b-3
Eliem Therapeutics Valuation on July 8, 2024
It is possible to determine the worth of Eliem Therapeutics on a given historical date. On July 8, 2024 Eliem was worth 6.72 at the beginning of the trading date compared to the closed value of 6.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eliem Therapeutics stock. Still, in general, we apply an absolute valuation method to find Eliem Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eliem Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eliem Therapeutics' related companies.
Open | High | Low | Close | Volume | |
6.85 | 7.15 | 6.55 | 6.63 | 267,769 | |
07/08/2024 | 6.72 | 6.95 | 6.65 | 6.78 | 138,457 |
6.72 | 6.82 | 6.50 | 6.55 | 106,416 |
Backtest Eliem Therapeutics | | | Eliem Therapeutics History | | | Eliem Therapeutics Valuation | Previous | Next |
Eliem Therapeutics Trading Date Momentum on July 8, 2024
On July 09 2024 Eliem Therapeutics was traded for 6.55 at the closing time. The top price for the day was 6.82 and the lowest listed price was 6.50 . The trading volume for the day was 106.4 K. The trading history from July 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.39% . The overall trading delta against the current closing price is 2.21% . |
Eliem Therapeutics Fundamentals Correlations and Trends
By evaluating Eliem Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eliem Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eliem financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eliem Therapeutics Stock history
Eliem Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eliem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eliem Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eliem Therapeutics stock prices may prove useful in developing a viable investing in Eliem Therapeutics
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
Eliem Therapeutics Stock Technical Analysis
Eliem Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Eliem Therapeutics Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Eliem Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eliem Therapeutics December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns
Eliem Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eliem Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eliem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eliem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.15) | |||
Jensen Alpha | (1.04) | |||
Total Risk Alpha | (1.59) | |||
Treynor Ratio | 1.76 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |